Slide 1: Q2 2023 Earnings call presentation
st Redcare Q2 2023 Earnings call presentation. @SEVENUM | 01 AUGUST 2023 _)
Slide 2: Presenting live from our Chief Financial Officer
Presenting live from our Chief Financial Officer. i / d FS Monica Ambrosi, Associate Director, Investor Relations. . ae
Slide 3: Today's agenda
Today’s agenda. Ci) Financial performance. C2) Update on business and strategy. €&> Outlook and guidance. BS ]
Slide 4: Financial performance
Financial - performance.
Slide 5: H1 2023 highlights
@ FINANCIAL PERFORMANCE Hi 2023 highlights. > Continued fast growth. Total sales up 46% in Q2 and 34% in Hi. Excl. MediService, beyond 20% growth too; 25% Q2, 24% Hi. Non-Rx sales growth 27% in Q2 and 25% in Hi. More than 10 million active customers. Gained 0.8M this half-year and 1.5M y.o.y. to 10.
Slide 6: Double-digit sales growth continues
Double-digit sales growth continues. Total DACH International +33.8% eC? EUR 168M EUR 592M Hi 2022 Hi 2023 Hi 2022 Hi 2023 Hi 2022 Hi 2023
Slide 7: Surpassing 10-million active customers
Surpassing 10-million active customers. Number of customers (NPs) & 7 Net Promoter Score Q2 2023 (2022: 74) 10.1M ® 8.6M +1.5M € 58.93 Average Shopping Basket Value June 2022 June 2023 Q2 2023 (2022: 57.96) BS ]
Slide 8: More than 14M orders in H1, high customer loyalty
@ NON-FINANCIAL KPIs More than 14M orders in H1, high customer loyalty. Share of repeat orders in percentage of total 4.2 4.0 4.0 82% 79% 83% ai Q2 Q3 2020 Q4 ai Number of orders in millions 5.5 Ou) 4.4 82% 83% 81% Q2 Q3 Q4 2021 Orders: sales to end-customers / patients (B2C) both own-stock and plat
Slide 9: EBITDA: effectiveness, efficiency, loyalty and scale
@ KEY FINANCIALS | PROFIT&LOSS _) EBITDA: effectiveness, efficiency, loyalty and scale. in millions of euros, adjusted numbers Sales Gross profit margin Selling & distribution margin Administrative cost margin Adj. EBITDA margin Adj. EBITDA EBITDA Adjustments in Hi 2023 EUR 6.9M (Hi 2022: EUR 12.7M)
Slide 10: Underlying gross profit margin up 0.9pp in H1
@ KEY FINANCIALS | GROSS PROFIT MARGIN ) Underlying gross profit margin up O.9pp in H1. Adjusted gross profit margin in percentage of sales 1.2 (0.0) (0.3) 27.2% 27.8% Hi 2022 Product Margin _ Country / Other Hi 2023 Hi 2023 @2 2022 22023 2.2023 (incl. Mix) Rx-OTC Mix including including MediService
Slide 11: Operational and marketing efficiencies up 3.5pp in H1
@ KEY FINANCIALS | SELLING & DISTRIBUTION RATIO ) Operational and marketing efficiencies up 3.5pp in H1. 1 Adjusted S&D costs in percentage of sales (25.7%) 2.9 4 Hi 2022 Marketing Shipping and Packaging 0.5 Operational Labour (0.2) Other (22.2%) Hi 2023 (20.8%) Hi 2023 including MediService (26.3%)
Slide 12: Cash up over the first 6 months
@ KEY FINANCIALS: CASH FLOW Cash up EUR 64 million over the first 6 months. Cash flow in millions of euros 19 180 31 Dec 2022 Cash and Operating result short-term adjusted for financial assets depreciation, taxes and provisions 12 58 Working capital movements (35) Investments 22 244 30 Jun 2023 Fina
Slide 13: Update on business and strategy
di e.) Update on business and strategy.
Slide 14: Business and strategy highlights
@ UPDATE ON BUSINESS & STRATEGY ) Business and strategy highlights. > Awarded MSCI AAA rating for Sustainability. Among top 4% best of our industry globally. > Launched rebranding of Redcare Pharmacy. Official ticker symbol change to RDC. > Strategic partnership with Galenica in MediService. Announc
Slide 15: New corporate brand successfully launched
¥ Redcare New corporate brand successfully launched. > Ticker change event on 13 June at Frankfurt Stock Exchange. > Upgraded to MDAX. BS ]
Slide 16: Our vision
Our vision. Until every human has their
Slide 17: Our role
‘Our role. The one-stop pharmacy guiding people through health. LZ Cs Yi
Slide 18: New corporate name, uniting our successful local hero brands
New corporate name, uniting our successful local hero brands. © German and Austrian webshops sv Redcare aan: ocr ae PHARMACY smart Redcare J mevi service CQ medapp & © s¥ Shop Apotheke
Slide 19: Another step in the right direction
Another step in the right direction. 2.700.000 14.000 7-day moving average of e-Rx 2460.000 4200 Nationwide roll-out of e-Rx in Germany by Gematik announced on 22 June 2023. 1.620.000 8.400 > Number of prescriptions redeemed keeps rising — 1.080.000 5.600 more than 2.5M by end July 2023. > But more
Slide 20: Redcare Pharmacy & Galenica
Redcare Pharmacy & Galenica. Strategic alliance of leaders in their field. the best of both worlds. For the period mid-May to the end of 2023, MediService sales of around EUR 300 million are expected. Assortment expansion of shop-apotheke.ch to include a broader range of Swiss products to better mee
Slide 21: Outlook and guidance
Slide 22: Full year 2023
Full year 2023 Non-Rx growth 20-30% (up from 10-20%). Total net sales EUR 1.7-1.8 billion. Adj. EBITDA margin 1.5-3% (up from 0.5-2.5%). Free cash flow EUR -20M to 20M. Free cash flow in the most commonly used definition, i.e. cash flow from operating activities plus investing activities excluding o
Slide 23: Questions
¥ Redcare questions. ask
Slide 24: Thank you
Thank fe | you. a @SEVENUM | 01 AUGUST 2023 ) ¥ Redcare